Skip to Content

Join the 'Genox' group to help and get support from people like you.

Genox News

For Breast Cancer Patients, Less Time on Hormonal Meds?

Posted 6 days ago by Drugs.com

THURSDAY, Dec. 7, 2017 – Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. In a trial of nearly 3,500 patients, researchers found that seven years of hormonal therapy was as effective as 10 years. By the study's end, more than three-quarters of women in both groups were alive and recurrence-free. The results are "important," according to experts attending the San Antonio Breast Cancer Symposium, where the study was released Thursday. "Potentially, there is a large group of patients who don't need 10 years of therapy," said Dr. Susan Domchek, of the University of Pennsylvania's Abramson Cancer Center. Domchek, who was not involved in the study, said decisions around hormonal therapy are often a source of "major discussion and angst" for patients and doctors. Hormonal therapy involves drugs ... Read more

Related support groups: Breast Cancer, Tamoxifen, Arimidex, Femara, Anastrozole, Letrozole, Aromasin, Breast Cancer - Adjuvant, Exemestane, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Emblon, Tamoxen, Genox, Teslac, Nolvadex D, Tamofen, Tamosin, Nolvadex

New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too

Posted 7 days ago by Drugs.com

WEDNESDAY, Dec. 6, 2017 – Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found. The drug, called ribociclib (Kisqali), was approved by the U.S. Food and Drug Administration in March for the treatment of postmenopausal women with advanced breast cancer. Now, experts say, the drug is just as effective for premenopausal women. In the trial, the treatment typically doubled the time a woman remained free of cancer progression – from roughly one year to two years. That benefit is "strikingly similar" to what's been seen in postmenopausal women, said Dr. Neil Iyengar, who specializes in treating breast cancer at Memorial Sloan Kettering Cancer Center in New York City. Breast cancer occurs most often in older women, and tumors that develop before menopause tend to be more aggressive, explained Iyengar. ... Read more

Related support groups: Breast Cancer, Tamoxifen, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Kisqali, Tamoxifen Hexal, Nolvadex, Letrozole/ribociclib, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin, Emblon, Ribociclib

Risk of Breast Cancer's Return Can Linger for Decades

Posted 8 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 8, 2017 – Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows. Cancer experts say the findings should help inform women's treatment decisions. Specifically, the researchers followed women with estrogen-receptor-positive breast cancer, which means the hormone helps fuel the cancer's growth. Standard treatment includes hormonal therapy – with drugs that block estrogen's effects – to help prevent a return of the cancer. All of the women in the study, nearly 63,000, were scheduled to receive the typical five years of hormonal therapy. Researchers found that while the women remained cancer-free for those five years, the risk for recurrence over the next 15 years was still significant. It was greatest for women whose initial cancer had spread to multiple lymph nodes near the breast by the ... Read more

Related support groups: Cancer, Breast Cancer, Tamoxifen, Arimidex, Anastrozole, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Tamoxifen Hexal, Genox, Nolvadex D, Tamofen, Tamosin, Emblon, Nolvadex, Soltamox, Tamone, Tamoxen

Can You Trust the Labels on Your Supplements?

Posted 2 Nov 2017 by Drugs.com

THURSDAY, Nov. 2, 2017 – Think you know what's in your favorite supplement? Think again. More than half of the herbal and dietary supplements analyzed by researchers contained ingredients that differed from the list on their labels. Some had hidden ingredients that might actually harm health, researchers said. Bodybuilding and weight-loss supplements, in particular, tended to contain ingredients not listed on their packaging, said lead researcher Dr. Victor Navarro, chair of hepatology for Einstein Medical Center in Philadelphia. Chemical analyses found that product labels did not reflect ingredients for 80 percent of bodybuilding and performance enhancement supplements, and 72 percent of weight-loss products, the researchers reported. "We found that half of the bodybuilding supplements in our analysis contained undeclared anabolic steroids," Navarro said. The researchers and health ... Read more

Related support groups: Dietary Supplementation, Tamoxifen, Vitamin/Mineral Supplementation and Deficiency, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Dietary Fiber Supplementation, Tamoxifen Hexal, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin, Emblon

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps to reduce health costs. To save money, nearly one in 10 said they had avoided doctor appointments. Eight percent had refused treatment; postponed filling or not filled prescriptions; or skipped doses of prescribed medications. And 7 percent said they had cut pills in half, according to the survey of more than 4,000 adults. Such measures can jeopardize treatment success, ASCO says. "We should all be alarmed that Americans are potentially risking not only their health, but also their lives, due to ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Fluorouracil, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Votrient, Letrozole, Tarceva

Breast Cancer More Lethal for Blacks Than Whites

Posted 16 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends. "We found that differences in insurance explained one-third of the total excess risk of death in non-elderly black women compared to white women diagnosed with early stage breast cancer, while differences in tumor characteristics explained approximately one-fifth of the excess risk," lead study author Ahmedin Jemal, of the American Cancer Society (ACS), and colleagues wrote. In 2014, breast cancer death rates were 41 percent higher among black women than among white women in the United States, the researchers said. To learn more about this disparity, the investigators looked at information on more than 550,000 non-elderly women with early stage breast cancer. Black women were more likely to be uninsured ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Anastrozole, Breast Cancer, Metastatic, Letrozole, Megestrol, Zoladex, Megace, Evista, Aromasin, Breast Cancer - Adjuvant, Casodex, Exemestane

Breast Cancer Patients On Opioid Treatment More Likely To Discontinue Hormones

Posted 11 Sep 2017 by Drugs.com

MONDAY, Sept. 11, 2017 – Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report. Use of prescription opioids such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found. "It's not a big secret that the U.S. uses more opioids than any other country in the world," said researcher Rajesh Balkrishnan, of the University of Virginia School of Medicine's department of public health sciences. "Clearly there has to be better management of opioids in the elderly cancer population," Balkrishnan said in a university news release. For the study, researchers analyzed follow-through rates for adjuvant endocrine therapy – commonly called hormone treatment – among more than ... Read more

Related support groups: OxyContin, Breast Cancer, Tamoxifen, Arimidex, Anastrozole, Breast Cancer, Metastatic, Vicoprofen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Genox, Nolvadex D, Soltamox, Tamone, Emblon, Tamoxen, Nolvadex, Tamofen, Tamosin

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. "It is our hope that this information can be used by patients and physicians when discussing the impact of cancer treatment decisions on survival," Johnson said in a school news release. Steve Jobs, co-founder and former CEO of Apple, is likely the most famous person who initially chose alternative medicine as a sole treatment. He eventually turned back to conventional medicine when the alternative medicine treatment didn't keep his pancreatic cancer at bay. But at that point, the cancer had ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Anastrozole, Letrozole, Xeloda, Megestrol, Zoladex, Megace, Evista, Pancreatic Cancer, Hydroxyurea

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Skin Cancer, Tarceva

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Prostate Cancer, Tamoxifen, Fluorouracil, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Anastrozole, Votrient, Brain Tumor, Letrozole

Most Breast Cancer Patients Have Help Choosing Treatments

Posted 10 Jul 2017 by Drugs.com

MONDAY, July 10, 2017 – Most women who've been diagnosed with breast cancer don't go it alone. Many breast cancer patients depend on family and friends to help them make treatment decisions, get to doctor appointments and seek out other resources. A new study finds half of women rely on three or more people to help them through it. "People just diagnosed with cancer are often scared and overwhelmed. Having another person to help them process information is important," said study lead author Lauren Wallner, an assistant professor of general medicine and epidemiology at the University of Michigan. "Physicians need to recognize that women involve other people in their treatment decisions," she added in a university news release. "These people represent an important group to provide information about treatment options." For the study, the researchers surveyed about 2,500 women who had ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Anastrozole, Breast Cancer, Metastatic, Letrozole, Tasigna, Megace, Zoladex, Megestrol, Evista, Sprycel, Herceptin

FDA Widens Access to 'Cooling Cap' to Stop Hair Loss in Cancer Patients

Posted 5 Jul 2017 by Drugs.com

WEDNESDAY, July 5, 2017 – More cancer patients may be able to ward off hair loss during chemotherapy treatment. A cooling cap approved in 2015 for use in breast cancer patients has won expanded approval from the U.S. Food and Drug Administration. The DigniCap Cooling System can now be used for patients with solid tumors, the FDA announced. The computer-controlled cap contains liquid that circulates and cools the scalp, narrowing blood vessels. This reduces how much of the chemotherapy drugs reach hair follicle cells, the FDA said. Cooling also decreases activity of hair follicles and slows cell division. The result: Chemo drugs don't affect them as much, according to the FDA. Hair loss is a common side effect of chemotherapy, especially during treatment of most solid tumor cancers. Hair may fall out all at once, little by little or become thin. It's usually temporary – and upsetting. ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Gleevec, Anastrozole, Breast Cancer, Metastatic, Letrozole, Tasigna, Megace, Megestrol, Zoladex, Evista, Sprycel, Herceptin

Many Women Mistaken on 'Side Effects' of Breast Cancer Drug

Posted 29 Jun 2017 by Drugs.com

THURSDAY, June 29, 2017 – Many women at high risk for breast cancer do not take the drug tamoxifen to prevent the disease, often because they confuse naturally occurring symptoms with side effects from the drug. That's the finding of a new study of nearly 4,000 women tracked for almost five years in the United Kingdom. One U.S. expert in breast cancer care wasn't surprised by the findings. "It is true that many women who take the drug are perimenopausal, and it appears that the symptoms the women experience may have nothing to do with the drug and are rather simply due to age," explained oncologist Dr. Stephanie Bernik. "This was already known by physicians, but it is always helpful to have a scientific report to back up the information you give a patient," said Bernik, who is chief of surgical oncology at Lenox Hill Hospital in New York City. Tamoxifen is used to treat women with any ... Read more

Related support groups: Hot Flashes, Breast Cancer, Menopausal Disorders, Tamoxifen, Postmenopausal Symptoms, Breast Cancer, Metastatic, Atrophic Vaginitis, Perimenopausal Symptoms, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Vaginal Dryness, Tamoxifen Hexal, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, the clinical trials studied extended life by 3.34 million years, the study found. SWOG estimates the dollar return on investment from federal funding at $125 for each year of life gained. "A lot of people with cancer have lived longer because of the therapies tested in our publicly funded trials," study leader Joseph Unger said in a SWOG news release. He is an assistant member of the Fred Hutchinson Cancer Research Center's Cancer Prevention Program in Seattle. "At the same time, the cost of ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Tretinoin, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Rituxan, Isotretinoin, Colorectal Cancer

Is Radiation Therapy Overused in Breast Cancer Care?

Posted 14 Mar 2017 by Drugs.com

TUESDAY, March 14, 2017 – More than half of older American women with early breast cancer may get more radiation therapy than needed, which significantly boosts medical costs, a new study indicates. Analyzing 2011 data on breast cancer patients, researchers estimated $164 million could have been saved by ordering a shorter radiation course. "Women who were eligible for shorter radiation courses or omission of radiation were still often receiving longer and more costly radiation courses," said study leader Dr. Rachel Greenup. She's an assistant professor of surgery at Duke University Medical Center Cancer Institute in Durham, N.C. However, Greenup and other experts said the study results might not be applicable to today because more women are receiving shorter courses of radiation than in 2011. For the study, Greenup's team used data on 43,000 breast cancer patients age 50 and older ... Read more

Related support groups: Cancer, Breast Cancer, Tamoxifen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nausea/Vomiting - Radiation Induced, Tamoxifen Hexal, Nolvadex, History - Radiation Therapy, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin, Emblon

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Breast Cancer - Male, McCune-Albright Syndrome, Breast Cancer - Palliative, Precocious Puberty

Genox Patient Information at Drugs.com